Natural health product · NPN 80130717
Seraforte
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed April 22, 2024; licence last revised June 7, 2024.
- Natural Product Number (NPN)
- 80130717
- Licence holder
- Aone Pharma Inc.
- Dosage form
- Capsule, delayed release
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- April 22, 2024
- Licence last revised
- June 7, 2024
Also sold as
Other product names on the same licence.
- FLASER FORTE
- SERRATEN
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Serrapeptase | 20,000 SPU | Serratia marcescens E-15 - Whole Cell |
| Serrapeptase | 10 mg | Serratia marcescens E-15 - Whole Cell |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Proteolytic Enzyme. Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous.
Non-medicinal ingredients
Magnesium stearate; Brown rice flour; Hypromellose; Gellan gum